Cara Therapeutics Inc (CARA) is near the middle in its industry group according to InvestorsObserver. CARA gets an overall rating of 62. That means it scores higher than 62 percent of stocks. Cara Therapeutics Inc gets a 53 rank in the Biotechnology industry. Biotechnology is number 8 out of 148 industries.
Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
Cara Therapeutics Inc (CARA) stock is lower by -1.23% while the S&P 500 has gained 0.62% as of 2:19 PM on Wednesday, May 27. CARA has fallen -$0.20 from the previous closing price of $16.31 on volume of 372,663 shares. Over the past year the S&P 500 is higher by 7.42% while CARA has fallen -10.40%. CARA lost -$2.55 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Cara Therapeutics Inc click here.
See more here:
Where Does Cara Therapeutics Inc (CARA) Stock Fall in the Biotechnology Field? - InvestorsObserver
Recommendation and review posted by G. Smith
